Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 3
2010 2
2011 7
2012 8
2013 7
2014 11
2015 6
2016 8
2017 13
2018 15
2019 20
2020 28
2021 44
2022 37
2023 53
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; KEYNOTE-048 Investigators. Burtness B, et al. Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1. Lancet. 2019. PMID: 31679945 Clinical Trial.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr, Srimuninnimit V, Laktionov KK, Bondarenko I, Kubota K, Lubiniecki GM, Zhang J, Kush D, Lopes G; KEYNOTE-042 Investigators. Mok TSK, et al. Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4. Lancet. 2019. PMID: 30955977 Clinical Trial.
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, Safran H, Dos Santos LV, Aprile G, Ferry DR, Melichar B, Tehfe M, Topuzov E, Zalcberg JR, Chau I, Campbell W, Sivanandan C, Pikiel J, Koshiji M, Hsu Y, Liepa AM, Gao L, Schwartz JD, Tabernero J; REGARD Trial Investigators. Fuchs CS, et al. Among authors: dos santos lv. Lancet. 2014 Jan 4;383(9911):31-39. doi: 10.1016/S0140-6736(13)61719-5. Epub 2013 Oct 3. Lancet. 2014. PMID: 24094768 Clinical Trial.
Telementored ultrasonography: a narrative review.
Duarte ML, Dos Santos LR, Iared W, Peccin MS. Duarte ML, et al. Among authors: dos santos lr. Sao Paulo Med J. 2022 Mar 14;140(2):310-319. doi: 10.1590/1516-3180.2020.0607.R2.15092021. eCollection 2022. Sao Paulo Med J. 2022. PMID: 35293938 Free PMC article. Review.
Synchronous odontogenic tumors: A systematic review.
Neumann BL, Só BB, Santos LG, Silveira FM, Wagner VP, Vargas PA, Dos Santos JN, Mosqueda-Taylor A, Fonseca FP, Schuch LF, Martins MD. Neumann BL, et al. Among authors: santos lg. Oral Dis. 2023 Oct;29(7):2493-2500. doi: 10.1111/odi.14401. Epub 2022 Nov 7. Oral Dis. 2023. PMID: 36218070 Review.
Long-term airway evolution after orthognathic surgery: Systematic Review.
Daluz ADJ, da Silva TVS, Tôrres BO, Costa DFN, Santos LAM. Daluz ADJ, et al. Among authors: santos lam. J Stomatol Oral Maxillofac Surg. 2022 Apr;123(2):191-198. doi: 10.1016/j.jormas.2021.04.006. Epub 2021 Apr 18. J Stomatol Oral Maxillofac Surg. 2022. PMID: 33882343 Review.
254 results